Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
IDT Biologika
What Does IDT Biologika Do?
IDT Biologika is a global Contract Development and Manufacturing Organization (CDMO) specializing in vaccines, viral vectors, cell and gene therapies, and oncolytic viruses. With over a century of experience in developing and manufacturing innovative biologics, IDT Biologika offers integrated services from early-stage development through to commercial manufacturing and packaging. They are committed to combating infectious diseases and advancing human and animal health worldwide by providing high-quality, reliable, and innovative solutions to their pharmaceutical and biotech partners.
Where Is IDT Biologika's Headquarters?
HQ Function
The Dessau headquarters serves as the central hub for R&D, process development, manufacturing of vaccines and biologics (viral vaccines, viral vectors, live attenuated vaccines, recombinant proteins), quality control, and corporate operations.
Notable Features:
State-of-the-art BSL-1 to BSL-3 manufacturing facilities, advanced laboratories for process development and analytics, extensive fill & finish capabilities including lyophilization, and significant investments in capacity for viral vectors and mRNA vaccines.
Work Culture:
A collaborative and innovative environment focused on scientific excellence, quality, and patient safety. Employees are dedicated to advancing public health through the development and manufacturing of critical biopharmaceutical products, emphasizing teamwork and continuous improvement.
HQ Significance:
The Dessau site is a cornerstone of IDT Biologika's global operations, leveraging over 100 years of expertise in vaccine development and production. It's a key European center for biopharmaceutical manufacturing, critical for both pandemic preparedness and routine vaccine supply.
Values Reflected in HQ: The headquarters reflects IDT Biologika's core values of quality, innovation, reliability, and partnership. The advanced infrastructure and highly skilled workforce demonstrate a commitment to tackling global health challenges and delivering life-saving medicines.
Location:
IDT Biologika supports global health initiatives through its comprehensive contract development and manufacturing (CDMO) services for vaccines, viral vectors, cell & gene therapies, and other biologics. This includes process development, clinical trial material manufacturing, commercial-scale production, fill-finish, and quality control, serving clients across Europe, North America, Asia, and other international markets. Their primary manufacturing and development sites in Germany, along with their US presence, enable them to cater to regional and global supply chain needs for critical medicines.
Street Address:
Am Pharmapark
City:
Dessau-Rosslau
State/Province:
Saxony-Anhalt
Country:
Germany
Where Else Does IDT Biologika Operate Around the World?
Rockville, Maryland/USA
Address: 14200 Shady Grove Road, Suite 200, Rockville, MD 20850, USA
To provide US-based and international clients with accessible CDMO services, facilitate clinical trial material production, and strengthen IDT Biologika's presence in the important North American biopharmaceutical hub, supporting business development and project management.
Magdeburg (Barleben), Saxony-Anhalt/Germany
Address: Am Pharmapark, BioPharmaPark, Gebäude 20, 39179 Barleben, Germany
To provide specialized early-stage development expertise and capacity, supporting the innovation pipeline for new vaccines and biotherapeutics within Germany and Europe, complementing the larger manufacturing capabilities in Dessau.
Buying Intent Signals for IDT Biologika
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading IDT Biologika? Meet the Executive Team
As of April 2025, IDT Biologika' leadership includes:
Who's Investing in IDT Biologika?
IDT Biologika has been backed by several prominent investors over the years, including:
What Leadership Changes Has IDT Biologika Seen Recently?
IDT Biologika has seen significant leadership renewal in the past year (May 2023 - May 2024), with new appointments for the CEO and CFO roles, reflecting a strategic direction for continued growth and innovation in the biopharmaceutical CDMO sector.
Departures
New Appointments:
What Technology (Tech Stack) Is Used byIDT Biologika?
Discover the tools IDT Biologika uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
IDT Biologika Email Formats and Examples
IDT Biologika commonly utilizes the email format [first].[last]@[companydomain].com or [first].[last]@[companydomain].de. This is a standard structure for professional communication within the organization. The .com domain is typically used for international communications.
[first].[last]@idt-biologika.com
Format
jane.doe@idt-biologika.com
Example
85%
Success rate
What's the Latest News About IDT Biologika?
European Pharmaceutical Manufacturer • May 15, 2024
IDT Biologika news title: IDT Biologika expands fill-finish capacity for mRNA vaccines
IDT Biologika has announced an expansion of its fill-finish capabilities for mRNA vaccines at its Dessau, Germany site. This investment aims to meet the growing demand for mRNA-based therapeutics and vaccines, enhancing its capacity for aseptic filling and lyophilization....more
IDT Biologika Press Release • September 5, 2023
IDT Biologika news title: Alexandra Weyrather appointed as new CFO of IDT Biologika
IDT Biologika has appointed Alexandra Weyrather as its new Chief Financial Officer (CFO), effective September 1, 2023. She succeeds Frank-Mathias Knoebel and will be responsible for overseeing the company's financial strategy and operations....more
IDT Biologika Press Release • May 2, 2023
IDT Biologika news title: Dr. Ulrich Valley appointed as new CEO of IDT Biologika
Dr. Ulrich Valley has been appointed as the new Chief Executive Officer of IDT Biologika, effective May 1, 2023. He takes over from Jürgen Betzing and will lead the company's strategic growth in the biopharmaceutical CDMO market....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including IDT Biologika, are just a search away.